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Abstract: Idiopathic pulmonary fibrosis (IPF) is an aggressive disease in which normal lung
parenchyma is replaced by a stiff dysfunctional scar rich in activated fibroblasts and collagen-I.
We examined how the mechanochemical pro-fibrotic microenvironment provided by matrix stiffening
and TGF-β1 cooperates in the transcriptional control of collagen homeostasis in normal and fibrotic
conditions. For this purpose we cultured fibroblasts from IPF patients or control donors on hydrogels
with tunable elasticity, including 3D collagen-I gels and 2D polyacrylamide (PAA) gels. We found that
TGF-β1 consistently increased COL1A1 while decreasing MMP1 mRNA levels in hydrogels exhibiting
pre-fibrotic or fibrotic-like rigidities concomitantly with an enhanced activation of the FAK/Akt
pathway, whereas FAK depletion was sufficient to abrogate these effects. We also demonstrate a
synergy between matrix stiffening and TGF-β1 that was positive for COL1A1 and negative for MMP1.
Remarkably, the COL1A1 expression upregulation elicited by TGF-β1 alone or synergistically with
matrix stiffening were higher in IPF-fibroblasts compared to control fibroblasts in association with
larger FAK and Akt activities in the former cells. These findings provide new insights on how matrix
stiffening and TGF-β1 cooperate to elicit excessive collagen-I deposition in IPF, and support a major
role of the FAK/Akt pathway in this cooperation.
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1. Introduction
Idiopathic pulmonary fibrosis (IPF) is a very aggressive rare disease in which the normally soft
lung parenchyma is progressively and irreversibly replaced by a stiff dysfunctional scar [1]. Although
its etiology remains unknown, IPF has been associated with the appearance of fibroblast foci, which are
areas rich in activated fibroblasts/myofibroblasts in the background of excessive collagen deposition
(mostly type I collagen) indicative of active fibrosis [1,2]. Likewise the excessive accumulation and
pathologic activation of fibroblasts are hallmarks of fibrotic processes in other organs [3]. Accordingly
there is growing interest in understanding what drives myofibroblast misbehavior and their associated
aberrant collagen deposition in IPF and other types of organ fibrosis.
Type I collagen (collagen-I) is the most abundant extracellular matrix (ECM) component in
both normal and fibrotic conditions. Collagen-I has a triple helix structure that arises from two α-1
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and one α-2 chains, which are the products of the COL1A1 and COL1A2 genes, respectively [4,5].
The accumulation of collagen-I is thought to arise from an imbalance between collagen expression
by fibroblasts and its degradation through collagenases [6,7]. Among the latter, the matrix
metalloproteinase 1 (MMP-1) is the archetype of secreted collagenase [8]. In addition collagen-I
can be degraded by other secreted MMPs including MMP-2, MMP-8 and MMP-13 [9,10]. However
MMP-1 and MMP-2 are the most highly expressed collagenolytic MMPs in IPF [1,8].
Although the mechanisms underlying the excessive collagen deposition in IPF remain poorly
understood, such aberrant deposition has been associated with persistent fibroblast activation [11,12].
Transforming growth factor beta-1 (TGF-β1) is the most potent fibroblast activator known to date, and
has been pointed as a key pro-fibrotic cytokine in organ fibrosis in general and IPF in particular [11–13].
Intriguingly, in vitro studies have revealed that exogenous TGF-β1 triggers a transcriptional program
in normal fibroblasts that favors collagen deposition by increasing COL1A1 while decreasing MMP1
expression [14,15], although the underlying mechanisms remain poorly defined. In addition to TGF-β1,
there is solid evidence that ECM stiffening can also act as a potent pro-fibrotic mechanical stimulus [16],
and may enhance COL1A1 expression in fibroblasts per se [7,17,18]. Moreover, it should be noted that
previous in vitro studies on the inverse (transcriptional) regulation of COL1A1 and MMP1 by TGF-β1
were carried out in fibroblasts cultured on standard two-dimensional (2D) tissue culture plastic, which
is an extremely rigid material with a characteristic stiffness that is several orders of magnitude higher
than any normal or fibrotic tissue [19,20].
Since fibroblasts are very sensitive to their local mechanical microenvironment, it is conceivable
that matrix rigidity modulates inverse (transcriptional) regulation of COL1A1 and MMP1 by TGF-β1
in fibroblasts. However the nature of the interaction between matrix rigidity and TGF-β1 and how
it becomes altered in IPF remain poorly understood. To address this gap of knowledge, we cultured
primary pulmonary fibroblasts from control tissues and IPF patients in hydrogels with tunable elasticity
in the absence or presence of TGF-β1, and examined the expression of both COL1A1 and two important
collagenases that are upregulated in IPF (i.e., MMP1 and MMP2). Moreover, we examined the potential
roles of focal adhesion kinase (FAK) and Akt in matrix rigidity modulation of TGF-β1 regulation of
collagen homeostasis in normal and IPF-fibroblasts.
2. Results
2.1. Optimizing 2D and 3D Hydrogels with Tunable Elasticity to Mimic Normal and Pro-Fibrotic Mechanical
Microenvironments
Mammalian pulmonary tissue is rather soft and elastic, with a stiffness defined by a Young’s
elastic modulus (E)—which is the physical parameter commonly used to characterize a sample’s
resistance to deformation [21]—in the range of ~3–10 kPa in bulk [22–25] and ~0.1–5 kPa at the
nanometer scale [7] as summarized in Table 1. Normal tissue elasticity becomes compromised
in pulmonary fibrosis, with a 2–3 fold increase in bulk tissue stiffness [24,26], and up to 30-fold
stiffening at the nanometer-scale [7]. To culture fibroblasts in conditions that mimic the fibrotic
mechanical microenvironment, we adapted two independent and complementary assays based
on collagen-rich hydrogels with tunable elasticity as outlined in Figure 1. Both assays have been
widely used in previous mechanobiology studies [27,28]. The floating gel assay is based on culturing
fibroblasts embedded in three-dimensional (3D) collagen-I gels that remain either attached to their
container or floating, thereby providing high or low mechanical resistance, respectively. Based on our
previous work, we used dense collagen-I gels at the highest accessible concentration (4 mg/mL) to
achieve the largest stiffness, which corresponds to E = 0.82 ± 0.19 kPa as assessed by nanoindentation
measurements by atomic force microscopy (AFM) [29]. Likewise previous AFM measurements
carried out by us and others have reported an average 3.3-fold higher E in attached compared to
floating gel conditions [27,30,31]. Using the latter value we computed the expected E for floating
4 mg/mL collagen-I gels as shown in Figure 1A, which remained within the normal-like (floating)
or pre-fibrotic-like (attached) range as summarized in Table 1, but failed to reach fibrotic values.
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Alternatively we prepared two-dimensional (2D) collagen-I coated polyacrylamide (PAA) gels at
different acrylamide and bis-acrylamide concentrations. AFM measurements on PAA gels are shown
in Figure 1B and revealed that these gels cover the physiopathologic range of E values [20,21]. Based on
these data, we chose PAA gels exhibiting 0.6 and 28 kPa as models for normal-like and fibrotic-like
rigidities, respectively, in subsequent experiments.
Table 1. Reported Young’s elastic moduli or elastance (*) of normal pulmonary tissue.
Species Young’s Modulus or Elastance (*) Bulk/Nano-Scale (Technique) Reference
human 3–3.6 kPa bulk (indentation test) [23]
porcine ~10 kPa bulk (magnetic resonance elastography) [22]
porcine ≤4 kPa bulk (magnetic resonance elastography) [32]
dog ~5 kPa bulk (uniaxial oscillatory stretch) [33]
mouse 0.1–5 kPa (*) nanometer-scale (AFM) [7]
rat 5–10 kPa (*) bulk (uniaxial oscillatory stretch) [24]
rat 13 kPa bulk (uniaxial oscillatory stretch) [26]
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Figure 1. Cell culture substrata with tunable elasticity. (A) Top: Young’s elastic modulus of 3D 
floating/attached 4 mg/mL collagen-I gels assessed by AFM nanoindentation measurements. Bottom: 
outline of the floating/attached gel assay. (B) Top: Young’s elastic modulus of collagen-I coated 2D 
polyacrylamide (PAA) gels prepared using different acrylamide (AA) and bis-acrylamide 
concentrations probed by AFM nanoindentation measurements. Bottom: outline of the 2D PAA gel 
assay. 
2.2. Combined Effect of TGF-β1 and Matrix Stiffening in the Expression of COL1A1 and Collagenolytic 
MMPs in Normal Fibroblasts Cultured in Dense 3D Collagen-I Gels 
Exogenous TGF-β1 was added to 3D cultures and maintained for ~4 days, which is enough time 
to diffuse throughout the collagen-I hydrogels [34]. TGF-β1 enhanced substantially COL1A1 
expression in primary fibroblasts derived from control tissue (n = 3) cultured in 3D collagen-I gels, 
increasing the mRNA levels by ~300% in normal-like (floating) gels (Figure 2A) and by ~400% in pre-
fibrotic-like (attached) gels (Figure 2B) with statistical significance. In addition we noticed that the 
total mRNA levels were moderately higher in attached compared to floating gels in either the absence 
(~25%) or presence (~50%) of TGF-β1, thereby suggesting a positive synergy between matrix 
stiffening and TGF-β1. These results reveal that the increase in COL1A1 expression by TGF-β1, which 
has been extensively reported in standard 2D tissue culture plastic [7,17], can be extended to the soft 
normal-like microenvironment elicited by 3D collagen-I gels. 
Figure 1. Cell culture substrata with tunable elasticity. (A) Top: Young’s elastic modulus of 3D
floating/attached 4 mg/mL collagen-I gels assessed by AFM nanoindentation measurements. Bottom:
outline of the floating/attached gel assay. (B) Top: Young’s elastic modulus of collagen-I coated 2D
polyacrylamide (PAA) gels prepared using different acrylamide (AA) and bis-acrylamide concentrations
probed by AFM nanoindentation measurements. Bottom: outline of the 2D PAA gel assay.
2.2. Combined Effect of TGF-β1 and Matrix Stiffening in the Expression of COL1A1 and Collagenolytic MMPs
in Normal Fibroblasts Cultured in Dense 3D Collagen-I Gels
Exogenous TGF-β1 was added to 3D cultures and maintained for ~4 days, which is enough
time to diffuse throughout the collagen-I hydrogels [34]. TGF-β1 enhanced substantially COL1A1
expression in primary fibroblasts derived from control tissue (n = 3) cultured in 3D collagen-I gels,
increasing the mRNA levels by ~300% in normal-like (floating) gels (Figure 2A) and by ~400% in
pre-fibrotic-like (attached) gels (Figure 2B) with statistical significance. In addition we noticed that the
total mRNA levels were moderately higher in attached compared to floating gels in either the absence
(~25%) or presence (~50%) of TGF-β1, thereby suggesting a positive synergy between matrix stiffening
and TGF-β1. These results reveal that the increase in COL1A1 expression by TGF-β1, which has been
extensively reported in standard 2D tissue culture plastic [7,17], can be extended to the soft normal-like
microenvironment elicited by 3D collagen-I gels.
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Unlike COL1A1, TGF-β1 induced a down-regulation of MMP1 in pre-fibrotic (attached) gels
(~−40%, Figure 2D), although it did not attain statistical significance. In contrast, TGF-β1 enhanced the
average MMP1 mRNA levels by ~140% in normal-like (floating) gels with statistical significance,
and such increase was consistently observed in fibroblasts from all donors (n = 3) (Figure 2C).
These findings reveal for the first time that the inverse (transcriptional) regulation of COL1A1 and
MMP1 by TGF-β1 reported in stiff culture substrata here and elsewhere [14,15] does not hold in soft
3D collagen-I gels exhibiting normal-like stiffness.
Unlike MMP1, MMP2 increased slightly upon TGF-β1 stimulation in floating (~60%) and attached
(~30%) gels, although such increase attained only statistical significance in the former conditions
(Figure 2E,F). Moreover, unlike MMP1 and COL1A1, MMP2 exhibited very similar mRNA levels in
both floating and attached gels. Similar percentages of active MMP2 and a weak regulation by TGF-β1
in both floating and attached conditions were also observed by gelatin zymography (Figure 2G, right
panels). Given the weak transcriptional modulation of MMP2 by either TGF-β1 or matrix stiffening,
we restricted our analysis to COL1A1 and MMP1 in subsequent experiments.
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spontaneous pneumothorax) cultured in 3D floating/attached collagen-I gels. (A,B) COL1A1 mRNA 
levels in floating (A) and attached (B) gels. (C,D) MMP1 mRNA levels in floating (C) and attached 
(D) gels. (E,F) MMP2 mRNA levels in floating (C) and attached (D) gels. (G) Representative gelatin 
zymogram showing the activity of secreted MMP2 (left panel). Corresponding quantification of the 
percentage of active MMP2 with respect to total MMP2 (pro-MMP2 + MMP2) (right panel). * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.005 here and thereafter were determined by paired Student’s t-test. Unless 
otherwise indicated, all fibroblasts were treated with TGF-β1 for ~4 days here and thereafter. 
Figure 2. Effect of TGF-β1 on the mRNA levels assessed by qRT-PCR of COL1A1 and MMP collagenases
in primary pulmonary fibroblasts derived from control tissue (n = 3, patients with spontaneous
pneumothorax) cultured in 3D floating/attached collagen-I gels. (A,B) COL1A1 mRNA levels in
floating (A) and attached (B) gels. (C,D) MMP1 mRNA levels in floating (C) and attached (D) gels.
(E,F) MMP2 mRNA levels in floating (C) and attached (D) gels. (G) Representative gelatin zymogram
showing the activity of secreted MMP2 (left panel). Corresponding quantification of the percentage of
active MMP2 with respect to total MMP2 (pro-MMP2 + MMP2) (right panel). * p ≤ 0.05, ** p ≤ 0.01,
*** p≤ 0.005 here and thereafter were determined by paired Student’s t-test. Unless otherwise indicated,
all fibroblasts were treated with TGF-β1 for ~4 days here and thereafter.
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2.3. Combined Effect of TGF-β1 and Matrix Stiffening in the Expression of COL1A1 and MMP1 in Normal
Fibroblasts Cultured in 2D Collagen-I Coated PAA Gels
To analyze the fibroblast transcriptional responses to TGF-β1 in a fibrotic-like mechanical
microenvironment, fibroblasts from control tissue where cultured in 2D collagen-I coated PAA gels
exhibiting either normal-like or fibrotic-like stiffness as described in Figure 1B. As in 3D cultures,
TGF-β1 enhanced the mRNA expression of COL1A1 in both soft (normal-like) and stiff (fibrotic-like)
PAA gels with statistical significance (Figure 3A,B). However, unlike 3D cultures, both the increase
in COL1A1 mRNA induced by TGF-β1 (~230%) and the range of mRNA levels were very similar
regardless the stiffness of the PAA gel. In addition we noticed that the mRNA levels were on average
~3.5-fold higher in 2D PAA gels compared to 3D collagen-I gels, revealing that the dimensionality of
the microenvironment modulates the transcriptional activity of TGF-β1.
Unlike 3D cultures, TGF-β1 down-regulated MMP1 mRNA in both 2D soft (normal-like) and stiff
(fibrotic-like) PAA gels by ~−30% and~−40%, respectively, and such down-regulation was statistical
significant in the latter conditions (Figure 3C,D). In addition the range of MMP1 mRNA was slightly
higher in stiff compared to soft PAA gels, and overall it was on average ~9-fold higher in 3D cultures
compared to 2D PAA gels, further expanding that the transcriptional activity of TGF-β1 is modulated
by the dimensionality of the culture conditions.
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Figure 3. Effect of TGF-β1 on the mRNA levels assessed by qRT-PCR of COL1A1 and MMP1 in
CCD-19Lu fibroblasts and primary pulmonary fibroblasts derived from uninvolved regions of surgical
lung cancer patients (n = 6) cultured in collagen-I coated 2D PAA gels. (A,B) COL1A1 mRNA levels in
gels exhibiting normal-like (A) or fibrotic-like (B) rigidities as shown in Figure 1B. (C,D) Corresponding
MMP1 mRNA levels of fibroblasts cultured as in B-C. Statistical analysis as in Figure 2.
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Altogether our results reveal that TGF-β1-dependent inverse regulation of COL1A1 and MMP1
mRNAs is similar qualitatively but not quantitatively in the stiff conditions elicited by either pre-fibrotic
3D collagen-I gels or fibrotic-like 2D PAA gels. In contrast the mRNA levels of MMP1 induced by
TGF-β1 in the softest conditions were strongly dependent on the dimensionality of the culture assay.
2.4. Linear Modeling of the Combined Effect of TGF-β1 and Matrix Stiffening in Gene Expression
To analyze quantitatively the potential interaction between TGF-β1 and matrix stiffening in
regulating the mRNA of a specific gene (R), we used a simple linear model in the form:
R = Ro + a∆E + b∆C + ξ∆E∆C
where Ro is the basal mRNA expression in a soft microenvironment in the absence of TGF-β1, ∆E and ∆C
are the increase in either gel rigidity (E) or TGF-β1 concentration (C), a and b are proportionality factors
between gene expression and either stiffness (a) or TGF-β1 concentration (b), and ξ is the interaction or
coupling factor between stiffness and TGF-β1 concentration. The relationship between the experimental
values of each condition and the model is as follows: Rsoft = Ro, Rsoft+TGF-β1 = Ro + b∆C, Rstiff = Ro + a∆E
and Rstiff+TGF-β1 = Ro + a∆E + b∆C + ξ∆E∆C.
According to our linear model, the ratio between the difference of gene expression with or without







Therefore, the prediction of the model is that ∆Rstiff/∆Rsoft = 1 in the absence of interaction
(i.e., ξ = 0), whereas ∆Rstiff/∆Rsoft 6= 1 otherwise (ξ 6= 0).
To compare the predictions of the model with our data, we computed the ratio ∆Rstiff/∆Rsoft for
each patient and assay, and the corresponding averages are shown in Figure 4. These computations
revealed that the average ratio ∆Rstiff/∆Rsoft was consistently ~1.5-fold higher for COL1A1 in the stiffest
conditions elicited by both 3D cultures (Figure 4A) and 2D PAA gels (Figure 4B), although it attained
statistical significance in the former assay only. Likewise, ∆Rstiff/∆Rsoft for MMP1 was consistently
<−0.5 lower and statistically significant in the stiffest conditions in both assays (Figure 4C,D). Therefore
this analysis demonstrates that TGF-β1 and matrix stiffening do synergize at the transcriptional level
positively for COL1A1 and negatively for MMP1. In contrast we found only a modest positive synergy
between TGF-β1 and matrix stiffening for MMP2 in 3D cultures (Supplementary Materials Figure S1).
2.5. Inverse Regulation of COL1A1 and MMP1 mRNA Levels by TGF-β1 Is Associated with the Activation of
the FAK/Akt Pathway
A large body of work has underlined the key role of integrin ECM receptors in sensing the
mechanical microenvironment and transducing it into biological responses in fibroblasts and other
cell types [27,35,36]. Moreover, we recently reported that matrix stiffening alone increases integrin
mechanosensing in lung fibroblasts through phosphorylation of focal adhesion kinase (FAK) at
tyr397 (FAKY397), which in turn enhanced the activity of its downstream target Akt [37] through
phosphorylation at S473 (AktpS473) [35]. In addition, other groups have shown that TGF-β1 increases
both FAKY397 and AktpS473 in fibroblasts in 2D cultures [38]. Moreover, Akt inhibitors have consistently
elicited a reduction in COL1A1 concomitantly to an increase in MMP1 in fibroblasts [15]. Therefore all
these previous observations raise the possibility that the inverse regulation of COL1A1 and MMP1
by TGF-β1 may involve the FAK/Akt pathway. To examine this possibility we first conducted a
time-course analysis of Akt activation by phosphorylation at Ser473 upon TGF-β1 stimulation in
fibroblasts cultured in standard tissue culture plastic substrata (i.e., 2D culture), and found a robust
Akt activation at 6 h (Figure 5A and Supplementary Materials Figure S2). Next we took advantage of a
well-established genetic model based on mouse embryonic fibroblasts that are either FAK wild-type
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(FAK+/+) or FAK null (FAK−/−) [39]. TGF-β1 stimulation induced an increase in AktpS473 after 6 h in
FAK+/+ but not in FAK−/− fibroblasts cultured in the stiff conditions provided by standard 2D cultures
(Figure 5B). Likewise 4-day treatment with TGF-β1 increased Col1a1 while decreasing Mmp1a mRNA
levels in FAK+/+ fibroblasts (Figure 5C,D), which are the mouse equivalent to COL1A1 and MMP1,
respectively. In contrast mRNA levels of Col1a1 where two orders of magnitude lower in FAK−/−
compared to FAK+/+ fibroblasts and failed to increase upon TGF-β1 stimulation (Figure 5C), whereas
Mmp1a could not be detected in FAK−/− fibroblasts even after increasing the amount of cDNA by
5-fold on the qRT-PCR system (Figure 5D). These results reveal that FAK is necessary for the inverse
regulation of Col1a1 and Mmp1a mRNA levels by TGF-β1 in stiff microenvironments, and is associated
with increased Akt activity.
Int. J. Mol. Sci. 2017, 18, 2431 7 of 18 
 
in FAK+/+ but not in FAK−/− fibroblasts cultured in the stiff conditions provided by standard 2D 
cultures (Figure 5B). Likewise 4-day treatment with TGF-β1 increased Col1a1 while decreasing 
Mmp1a mRNA levels in FAK+/+ fibroblasts (Figure 5C,D), which are the mouse equivalent to COL1A1 
and MMP1, respectively. In contrast mRNA levels of Col1a1 where two orders of magnitude lower in 
FAK−/− compared to FAK+/+ fibroblasts and failed to increase upon TGF-β1 stimulation (Figure 5C), 
whereas Mmp1a could not be detected in FAK−/− fibroblasts even after increasing the amount of cDNA 
by 5-fold on the qRT-PCR system (Figure 5D). These results reveal that FAK is necessary for the 
inverse regulation of Col1a1 and Mmp1a mRNA levels by TGF-β1 in stiff microenvironments, and is 
associated with increased Akt activity. 
 
Figure 4. Analysis of the potential transcriptional synergy between TGF-β1 and matrix stiffening on 
COL1A1 and MMP1 in control primary pulmonary fibroblasts. (A,B) Average difference in COL1A1 
expression with our without TGF-β1 measured in soft and stiff substrata in each patient and 
normalized to the corresponding difference obtained in soft substrata using 3D collagen-I gels (A) or 
2D PAA gels (B). Patients were the same than those used in Figures 2 and 3. (C,D) Corresponding 
fold change in MMP1. Horizontal dashed line indicates no fold change. Further details are given in 
the main text. * p ≤ 0.05 with respect to no change (1) were determined by Student’s t-test. 
Figure 4. Analysis of the potential transcriptional synergy between TGF-β1 and matrix stiffening on
COL1A1 and MMP1 in control primary pulmonary fibroblasts. (A,B) Average difference in COL1A1
expression with our without TGF-β1 measured in soft and stiff substrata in each patient and normalized
to the corresponding difference obtained in soft substrata using 3D collagen-I gels (A) or 2D PAA
gels (B). Patients were the same than those used in Figures 2 and 3. (C,D) Corresponding fold change
in MMP1. Horizontal dashed line indicates no fold change. Further details are given in the main text.
* p ≤ 0.05 with respect to no change (1) were determined by Student’s t-test.
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Figure 5. Analysis of FAK-Akt crosstalk in the inverse transcriptional regulation of Col1a1 and Mmp1a
by TGF-β1 in stiff microenvironments in FAK wild-type (FAK+/+) and FAK null (FAK−/−) fibroblasts.
(A) Representative Western blot showing the time-course expression of AktpS473, total Akt and β-actin
in fibroblasts stimulated with TGF-β1 up to 6 h. (B) Representative Western blot showing AktpS473,
total Akt and α-tubulin of FAK+/+ and FAK−/− fibroblasts stimulated with TGF-β1 for 6 h; (right)
corresponding densitometry analysis of AktpS473/Akt (n = 3). (C,D) Corresponding mRNA levels of
Col1a1 (C) and Mmp1a (D) of fibroblasts stimulated with TGF-β1 for ~4 days. Mmp1a could not be
detected in FAK−/− fibroblasts. Two-group comparisons were performed by Student’s t-test.
2.6. Fibroblasts fro IPF Patients Exhibit Aberrant Transcriptional Responses to TGF-β1 and Matrix Stiffening
in Terms of Both COL1A1 and MMP1 Concomitantly with Enhanced Activation of the FAK-Akt Pathway
Finally, we xamined to fi roblast responses to the mechanochemical pro-fibrotic
conditions provided by stif c l trata and TGF-β1 become aberrant in IPF in terms f both
COL1A1-M P1 expressio a t e acti ity of the FAK-Akt pathway. For this purpose, primary
fibroblasts isolated from IPF patients ere cultured in either pre-fibrotic 3D collagen-I gels or fibrotic
2D collagen-I coated PAA gels as described in Figure 1, and their responses to TGF-β1 were compared
to those observed in fibroblasts from control pulmonary tissue. IPF-fibroblasts exhibited consistently
larger mRNA COL1A1 levels when cultured in stiff substrata in the presence of TGF-β1 compared to
fibroblasts from control tissue, although to a larger extent in 3D gels (~1.7-fold) (Figure 6A) than 2D PAA
gels (~1.2-fold) (Figure 6B). Likewise, MMP1 mRNA levels were consistently larger in IPF-fibroblasts
compared to normal fibroblasts in 3D cultures (~4.7-fold) (Figure 6D) and 2D PAA gels (~1.15-fold)
(Figure 6E), although the latter difference did not attain statistical significance. These results reveal that
IPF-fibroblasts exhibit abnormally high mRNA levels of COL1A1 and possibly of MMP1 when cultured
in pro-fibrotic mechanochemical conditions. Furthermore, we analyzed the potential synergy between
matrix stiffening and TGF-β1 in IPF-fibroblasts by computing ∆Rstiff/∆Rsoft using data gathered with
the 3D collagen-I gel assay. Remarkably ∆Rstiff/∆Rsoft of COL1A1 was ~2-fold higher in IPF-fibroblasts
compared to control fibroblasts with statistical significance (Figure 6C), revealing an aberrant positive
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synergy between matrix stiffening and TGF-β1 in IPF-fibroblasts far beyond that of normal fibroblasts.
In contrast, MMP1 data elicited ∆Rstiff/∆Rsoft >1 in IPF-fibroblasts, whereas such ratio was negative in
control fibroblasts (Figure 6F), revealing an aberrant positive synergy between matrix stiffening and
TGF-β1 in IPF-fibroblasts in terms of MMP1 expression.
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Figure 6. Aberrant transcriptional regulation of COL1A1 and MMP1 elicited by pro-fibrotic conditions
(TGF-β1 and stiff substrata) in IPF-fibroblasts. (A,B) COL1A1 mRNA levels of pulmonary fibroblasts
derived from either control or IPF patients cultured in attached 3D collagen-I gels (A, n = 3) or ~28 kPa
2D PAA gels (B, n = 5); control patients were the same than those used in Figures 2 and 3, respectively
(C) Potential synergistic interaction between TGF-β1 and matrix stiffening in terms of COL1A1 in
control and IPF-fibroblasts cultured in 3D collagen-I gels assessed as in Figure 4A. (D–F) Corresponding
MMP1 mRNA levels (D,E)and potential synergy between TGF-β1 and matrix stiffening (F) in control
and IPF-fibroblasts cultured as in A-B and C, respectively. (G) Representative Western blot showing
AktpS473, total Akt and β-actin of control fibroblasts and IPF fibroblasts stimulated with TGF-β1 for
6 h; (right) corresponding de sitometry analysis of AktpS473/Akt in control (n = 4) and IPF fibroblasts
(n = 4). Two group comparisons were performed by Student’s t-test.
With regards to the activity of the FAK/Akt pathway, we recently reported enhanced FAKY397 in
IPF-fibroblasts compared to fibroblasts from control tissue upon TGF-β1 stimulation using standard
2D cultures [40]. To assess the FAK/Akt pathway further, we examined Akt activity in IPF-fibroblasts
and control fibroblasts cultured in 2D and activated by TGF-β1, and found a larger increase in AktpS473
in IPF-fibroblasts after 6 h as shown in Figure 6G, although it did not attain statistical significance.
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Thus, these results suggest that the enhanced activity of the FAK/Akt pathway may underlie, at least
in part, the aberrant collagen homeostasis in IPF-fibroblasts.
3. Discussion
3.1. First Evidence That the Inverse Regulation of COL1A1 and MMP1 mRNA Levels by TGF-β1 in Normal
Fibroblasts Does Not Hold in Soft (Normal-Like) 3D Microenvironments
How the mechanical microenvironment and TGF-β1 cooperate to control collagen deposition
in normal and fibrotic conditions had remained poorly understood. Of note, previous studies with
2D cultures had revealed that TGF-β1 transcriptionally increases COL1A1 while decreasing MMP1 in
normal fibroblasts [14,15]. Such inverse regulation was also observed in the present study in fibroblasts
from control tissue cultured in both pre-fibrotic and fibrotic-like rigidities elicited by attached 3D
collagen-I gels and stiff 2D PAA gels, respectively. However, to our surprise the inverse regulation
of COL1A1 and MMP1 mRNA levels by TGF-β1 was also observed in soft 2D PAA gels but not
in soft (normal-like) 3D collagen-I gels, even though both gel types exhibited similar stiffnesses.
This discrepancy reveals for the first time that the inverse regulation of COL1A1 and MMP1 mRNA
levels by TGF-β1 is not universal but rather strongly dependent on the mechanics and dimensionality
of the microenvironment.
Since 3D cultures are expected to be better tissue surrogates than 2D cultures [41,42],
our observations in soft 3D collagen-I gels are likely to be more physiologically relevant than those in
soft 2D PAA gels. Because an inverse transcriptional regulation is expected to contribute to collagen
deposition by reducing collagen-I degradation while increasing its expression [6,7], it is conceivable
that the loss of such inverse regulation in soft (normal-like) 3D microenvironments may prevent a
large increase in collagen-I deposition, which could be beneficial for normal wound healing. However
the functional implications of the loss of the inverse regulation of COL1A1-MMP1 mRNA levels by
TGF-β1 in soft 3D microenvironments remain to be elucidated.
3.2. First Direct Quantitative Evidence of Transcriptional Synergy between Matrix stiffening and TGF-β1 and
the Potential Role of the FAK/Akt Pathway
Few previous studies have examined the impact of matrix stiffening alone on fibroblasts in terms
of COL1A1 transcription [7,17,18,43], and even less in terms of MMP1 [7]. In the absence of TGF-β1,
2D PAA gels and 3D cultures elicited an increase of COL1A1 in the range of ~10–25%, which is similar
to the ~20% increase in COL1A1 reported in cardiac and pulmonary fibroblasts cultured in 2D PAA
gels [7,18]. However our observed increase in COL1A1 was lower than the 150–190% increase reported
in other studies using either 3D cultures or 2D PAA gels [17,18,43], which may be associated with
distinct experimental conditions or tissue of origin. On the other hand, we found that matrix stiffening
in the absence of TGF-β1 increased MMP1 by ~1% in 3D cultures whereas it decreased MMP1 by ~80%
in 2D PAA gels, which is similar to the 70% decrease in 2D PAA gels reported elsewhere [7]. However
to our knowledge this is the first study that provides direct quantitative evidence for an inverted
transcriptional synergy between matrix stiffening and TGF-β1 in fibroblasts, which was positive for
COL1A1 and negative for MMP1.
With regards to mechanisms, four lines of evidence support that the FAK/Akt pathway may have
an important role in the transcriptional co-regulation of collagen homeostasis by both TGF-β1 and
matrix stiffening. First, Akt is a known downstream target of FAK activity through PI3k [37,44,45].
Second, the activities of FAKY397 and AktS473 are upregulated by both matrix rigidity [19,35] and
TGF-β1 [38,46]. Third, pharmacologic inhibition of Akt or its downstream target mTOR has
consistently elicited the downregulation of collagen-I concomitantly with the upregulation of MMP1 in
fibroblasts [15,47,48]. Fourth, Akt was required for the increase of collagen expression by mechanical
stretch elsewhere [49]. However, in addition to the FAK/Akt pathway, we can envision other
potential mechanisms underlying the transcriptional regulation of collagen homeostasis by matrix
rigidity and TGF-β1 based on previous observations, including direct changes in TGF-β expression
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induced by matrix stiffening [50,51], osteopontin upregulation [52] or a crosstalk between the matrix
stiffening-sensitive transcription factors YAP/TAZ and regulatory SMADs [53]. Thus, the final
elucidation of the key mechanism requires future investigations.
3.3. Comparing Fibroblast Responses to Matrix Stiffening and TGF-β1 Using 2D and 3D Culture Assays
Provides New Insights on the Role of Matrix Dimensionality in Regulating Transcriptional Responses
in Fibroblasts
3D cultures are expected to be more physiologically relevant than traditional 2D cultures because
they provide critical cues from the tissue microenvironment, including adhesion to native ECM
components and a 3D architecture [41,42]. However current 3D cultures based on collagen-I gels
are somewhat limited for mechanobiology studies in the context of fibrosis because they do not
capture the full stiffening reported in pulmonary fibrosis [7,24,54]. In contrast 2D PAA gels cover
the stiffening of pulmonary fibrosis but miss the 3D architecture of tissues. Despite their differences,
both 3D cultures and 2D PAA gels revealed consistently an upregulation of COL1A1 concomitantly
with a downregulation of MMP1 upon TGF-β1 stimulation in the stiffest gel conditions but not in the
softest conditions. This discrepancy revealed that TGF-β1 transcriptional regulation of MMP1 depends
strongly on the dimensionality of the fibroblast microenvironment. Likewise we found marked and
opposite differences in the total levels of mRNA in COL1A1 and MMP1 between 3D cultures and
2D PAA gels, in which COL1A1 were higher and MMP1 lower in the latter gels. The larger mRNA
COL1A1 levels in 2D PAA gels are consistent with previous studies reporting increased metabolic and
transcriptional activities in cells cultured in 2D compared to 3D gels [55,56], which was associated
in part with an increased demand for endogenous ECM in the former conditions [56,57]. In contrast
the larger MMP1 expression in 3D cultures could reflect an excessive collagen-I concentration in
these gels. On the other hand it is worth noting that a previous study reported cellular responses
in response to matrix stiffening using both 2D PAA gels and 3D floating/attached gels that were
consistent qualitatively but not quantitatively in terms of expression of differentiation markers [27].
Collectively the latter study and our results support that comparing 2D and 3D gels with tunable
elasticity is a suitable approach to identify those cellular responses that are largely driven by matrix
stiffening rather than matrix dimensionality.
3.4. Aberrant Collagen Homeostasis and FAK/Akt Activity in IPF-Fibroblasts, and How They May Contribute
to Fibrosis Progression
The regulation of COL1A1 mRNA by both matrix stiffening and TGF-β1 in IPF-fibroblasts
analyzed in this study were aberrant in two complementary aspects. First, the total mRNA levels
of COL1A1 were higher in IPF-fibroblasts compared to control fibroblasts, which is consistent with
previous observations [40,58]. Second, the positive interaction between matrix stiffening and TGF-β1
was also larger in IPF-fibroblasts than in fibroblasts from control tissue. Because there are numerous
examples of positive correlations between changes in collagen-I at mRNA and protein levels in
fibroblasts [7,15,59], it is expected that the two aberrant features of COL1A1 mRNA regulation of
IPF-fibroblasts reported here do contribute to the excessive collagen-I deposition at the protein level in
IPF. However it should be borne in mind that collagen-I deposition is highly complex, for it is regulated
at the transcriptional, posttranscriptional and secretory levels [4,5,60]. Therefore it is conceivable that
the excessive amount of collagen-I in IPF is contributed by regulatory processes other than the increased
mRNA reported here.
Of note our study also provided evidence that the aberrant COL1A1 expression in IPF-fibroblasts
may involve the FAK/Akt pathway, since both FAKY397 and AktS473 were upregulated in stiff substrata
in response to TGF-β1 compared to control fibroblasts, and FAK deletion was sufficient to abrogate
the increase in both AktS473 and COL1A1 upon TGF-β1 stimulation. In support to our interpretation,
FAKY397 activity was found to be increased within fibroblast foci in IPF [39,61,62]. Likewise both
FAK and Akt activities were upregulated in fibrotic areas in the bleomycin model of pulmonary
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fibrosis [63]. Moreover, it has been recently reported that Akt controls the activity of LARP6 in
lung fibroblasts, which is an essential regulator of both the translation of collagen mRNA and the
synthesis of collagen-I [64]. All these observations may have important translational consequences,
for they support that targeting the FAK/Akt pathway may be a suitable therapeutic approach against
IPF progression. In line with this hypothesis, different protein kinase inhibitors have successfully
reduced collagen deposition and myofibroblast population (two critical markers of organ fibrosis)
concomitantly with a reduction in the phosphorylation/activation of FAK and Akt in the bleomycin
model of pulmonary fibrosis [39,63,65].
The response of IPF-fibroblasts to pro-fibrotic biochemical and mechanical stimuli was also
aberrant in terms of MMP1 expression, since they did not exhibit a negative regulation unlike control
fibroblasts. However it should be pointed out that, even though MMP1 is among the molecules more
significantly overexpressed in IPF compared with control lungs [8,66], the overall contribution of
fibroblasts to the total MMP1 levels in IPF remains uncertain. Thus, previous studies have reported
that MMP1 expression in IPF is largely associated with epithelial cells, whereas it is virtually absent
in fibroblast foci [67,68]. Likewise the role of MMP1 in IPF remains unclear [8], although it has been
speculated to contribute to epithelial migration [1]. Unlike MMP1, MMP2 upregulation in IPF has
been associated, at least in part, with IPF-fibroblasts, and has been implicated in the tissue migration
of fibrocytes, particularly through basement membrane proteins, thereby potentially facilitating the
accumulation of these cells in IPF [8,69].
In summary our work provides new insights on the mechanobiology of normal collagen
homeostasis in fibroblasts and how it becomes awry in IPF, and support an important role of the
FAK/Akt pathway in collagen homeostasis in both normal and fibrotic conditions.
4. Materials and Methods
4.1. Isolation of Patient-Derived Lung Fibroblasts
All primary fibroblasts were isolated by outgrowth of tissue explants from pulmonary tissue as
reported elsewhere [70], and frozen stored in liquid nitrogen at passage 2–3 until use. All protocols were
approved by the Ethics Committees of the Hospital Clínic de Barcelona and the Universitat de Barcelona,
and patients gave their informed consent. Samples from histologically normal pulmonary tissue
were obtained from either patients undergoing surgical pleurodesis to treat recurrent spontaneous
pneumothorax (n = 3) [40,70] or from uninvolved pulmonary tissue of surgical patients with non-small
cell lung cancer (n = 6) [35], and were used to obtain primary control fibroblasts. Tissue samples from
IPF patients were obtained from lung biopsies of patients exhibiting the histopathological pattern of
usual interstitial pneumonia (n = 5).
4.2. Cell Culture in Standard 2D Tissue Culture Plastic (2D Culture)
The normal human fibroblast cell line CCD-19Lu (ATCC) and primary fibroblasts were propagated
in standard 2D cultures as previously described [35,40]. In brief, fibroblasts were fast thawed and
maintained in fibroblast culture media containing DMEM supplemented with 10% FBS (FBS Gold,
PAA Laboratories, GE Healthcare, Little Chalfont, UK) and antibiotics. Primary fibroblasts were
used up to 5–6 passages to prevent replicative senescence. Mouse embryonic fibroblasts (MEFs)
from wild-type (FAK+/+) or FAK-deficient (FAK−/−) mice (ATCC) were cultured in DMEM media as
reported elsewhere [39]. All cultures were kept in a 5% CO2 humidified incubator at 37 ◦C. For 2D
culture experiments, MEFs were seeded as either 12 × 103 cells/cm2 (FAK+/+) or 20 × 103 cells/cm2
(FAK−/−) in serum-free culture medium with or without 5 ng/mL human TGF-β1 (R&D Systems,
Minneapolis, MN, USA) for ~4 days.
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4.3. Cell Culture in 3D Collagen-I Gels
Collagen-I solution for 3D cultures was freshly prepared the day of the experiment as previously
described [29,34]. In brief, acid soluble collagen-I (Cellagen IAC-50, Koken, Tokyo, Japan) was
neutralized in DMEM to obtain a 4 mg/mL collagen solution. All 3D cultures were conducted
in 24 well plates. First, wells were pre-coated with a thin layer of collagen-I solution to prevent
cell migration. Second, fibroblasts were trypsinized and resuspended with collagen-I solution at
0.9 × 106 cells/mL, and 215 µL of this mixture were added to a well, incubated at 37 ◦C for 30 min,
and immediately hydrated with 90 µL of serum-free culture medium. All samples were kept in the
incubator until use. After 24 h, half of the gels were gently detached from the well container edge with
a sterile spatula, whereas the other half remained attached [27], and culture medium was replaced by
fresh serum-free medium in the absence or presence of 5 ng/mL human TGF-β1 (R&D Systems) for
~4 days.
4.4. Cell Culture in 2D PAA Gels
Collagen-I–coated polyacrylamide (PAA) gels were obtained following a similar protocol
described elsewhere [27,35,71]. In brief, gels were prepared by mixing variable ratios of acrylamide
(AA; 3–12%) and bis-acrylamide (BIS; 0.22–0.6%) (Bio-Rad, Hercules, CA, USA). After polymerization,
the PAA gel surface was derivatized with Sulfo-SANPAH (Thermo Scientific, Waltham, MA, USA)
and coated with 0.1 mg/mL collagen-I (Millipore, Billerica, MA, USA). Fibroblasts were seeded
at 8 × 103 cells/cm2 in serum-free culture medium with or without 5 ng/mL human TGF-β1
(R&D Systems) for ~4 days.
4.5. Elasticity Nanoindentation Measurements by AFM
The Young’s elastic modulus E of 3D collagen-I gels and 2D PAA gels was assessed with a
home-made stand-alone AFM adapted to an inverted optical microscope as described in detail
elsewhere [27,36]. In brief, AFM nanoindentation measurements were performed with low spring
constant cantilevers with pyramidal tips (nominal k = 0.03 N/m) (Microlever, Veeco, Santa Barbara,
CA, USA), which were calibrated using the thermal noise method [36]. For each gel location, three
force-displacement curves (F-z curves) were acquired at a moderate loading force (~1 nN); E of each
F-z curve was computed by least-squares fitting of a contact elastic model, and averaged over the three
F-z curves [27]. The same protocol was applied on at least 9 random gel locations to elicit the final E
estimate of the hydrogel.
4.6. qRT-PCR
Cell cultures were performed in triplicates for qRT-PCR analysis, which was conducted as reported
elsewhere [40]. Briefly for each sample, total RNA was isolated using the RNeasy Mini kit (QIAGEN)
and reverse-transcribed into cDNA using the High Capacity cDNA Reverse Transcription Kit and
RNase inhibitor (Applied Biosystems, Foster City, CA, USA). Unless otherwise indicated, real-time
PCR reactions were performed on 20–50 ng of each cDNA sample using TaqMan gene-specific primer
pairs and probes for human genes encoding COL1A1 (Hs00164004_m1), MMP1 (Hs00233958_m1),
MMP2 (Hs01548724_m1) and POLR2A (Hs00172187_m1, used as a reference gene) and for mouse genes
encoding for Col1a1 (Mm00801666_g1), Mmp1a (Mm00473485_m1) and Polr2a (Mm00839502_m1, used
as a reference gene) (Applied Biosystems). Reactions were carried out for 40 cycles (95 ◦C for 21 s and
60 ◦C for 20 s) in a 7900HT Fast Real-Time PCR System (Applied Biosystems). Relative gene expression
with respect to POLR2A (for human) or Polr2a (for mouse fibroblasts) was assessed as k·2−∆Ct, where k
is the ratio of the threshold numbers used for the target and the endogenous genes, respectively, and
∆Ct is the difference between the average Ct of the target and the reference (endogenous) genes [72].
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4.7. Assay of MMP-2 Activity
The activity of MMP-2 was visualized by gelatin zymography as described elsewhere [73]. Briefly,
protease inhibitors were added to each cell culture (complete EDTA-free protease inhibitor cocktail,
Roche, Basel, Switzerland), and the corresponding conditioned media was collected, concentrated
(Ultrafiltration Amicon, Milipore, Burlington, MA, USA) and subjected to electrophoresis in 10%
gelatin gels (Invitrogen, Carlsbad, CA, USA). Afterwards, proteins were renatured with a renaturing
buffer (Invitrogen) and gelatinase activity was observed upon incubation with a developing buffer
(Invitrogen) for 18 h at 37 ◦C. As a negative control, 10 nM EDTA was added to the developing buffer.
Gelatin gels were stained with Coomassie blue. Regions of enzymatic activity (proteolysis) appeared
as clear bands against a dark background.
4.8. Western Blotting
FAK and Akt activities were assessed by Western blotting as reported elsewhere [35]. In brief,
fibroblasts were lysed in extraction buffer supplemented with phosphatase and protease inhibitors.
Equal protein amounts were separated on a 10% Mini-PROTEAN TGX precast gels (Bio-Rad),
transferred to a PVDF membrane (GE Healthcare, Marlborough, MA, USA), blocked and incubated
overnight with primary antibodies against Akt, AktpS473 (9272 and 4060; Cell Signaling Technology,
Danvers, MA, USA), and α-tubulin (2144, Cell Signaling) or anti-β-actin (Sigma, Saint Louis, MI, USA).
The latter two proteins were used as loading controls. Protein bands were labeled and visualized by
chemiluminescence (ImageQuant LAS 4000, GE Healthcare), and the corresponding band intensities
were quantified with Image J.
4.9. Statistical Analysis
Comparisons of results obtained from fibroblasts from the same patients were carried out using
paired Student’s t-test. Otherwise we used unpaired Student’s t-test. Statistical analyses were
performed with SigmaStat (Systat Software, San Jose, CA, USA). Statistical significance was assumed
at p < 0.05. Data are given as mean ± SE.
Supplementary Materials: The following are available online at www.mdpi.com/1422-0067/18/11/2431/s1.
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